Skip to content
Home/Companies/Biotech/Splice Bio
Splice Bio

Splice Bio

Biotech·Spain·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Splice Bio?

Splice Bio is currently owned by Asabys Partners through Sabadell Asabys Health Innovation Investments (2019 vintage), since 2022.

Hand-verified · updated 2026-08-09

Asabys Partners
Investor
Asabys Partners
Sabadell Asabys Health Innovation Investments · 2019 · Life Sciences VC

Key facts

HQSpain
SectorBiotech
StatusActive
Websitesplice.bio

More from Sabadell Asabys Health Innovation Investments

Other portfolio companies in the same fund.

Accure Therapeutics
Active
BiotechSpain· 2025
Qida
Active
HealthTechSpain· 2025
XRHealth
XRHealth
Active
HealthTechUnited States· 2023
Agomab
Agomab
Exited 2026
BiotechBelgium· 2021
INBRAIN Neuroelectronics
INBRAIN Neuroelectronics
Active
MedTechSpain· 2020
Medasense
Medasense
Active
MedTechIsrael· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Splice Bio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Splice Bio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue